X @Bloomberg
Bloomberg·2026-04-21 23:24
Roche’s experimental multiple sclerosis pill sharply reduced relapses in late-stage trials, strengthening its case for approval even as concerns about its safety profile persist https://t.co/N6pdrEMHdN ...
Roche’s experimental multiple sclerosis pill sharply reduced relapses in late-stage trials, strengthening its case for approval even as concerns about its safety profile persist https://t.co/N6pdrEMHdN ...